MARTHA ALZAMORA: Open Payments
NPI 1942390141 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 11 payments from 4 companies in 2025. Trend: 2023 $304 · 2024 $239 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $291 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, UZEDY, CAPLYTA, REXULTI.
Industry payments across NY — which companies pay providers there.
